慢性リンパ球性白血病: 細胞死を遠ざける
1Department of Pediatrics and Adolescent Medicine, University of Ulm, Eythstrasse 24, 89075, Ulm. klaus-michael.debatin@uniklinik-ulm.de
Cell
|June 2, 2007
まとめ
この研究では,DAPK1遺伝子の発現低下が慢性リンパ球性白血病 (CLL) と関連していることが判明しました. このダウンレギュレーションは,疾患の家族型および散発型の両方の遺伝的および表遺伝的変化によって起こります.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- 慢性リンパ球性白血病 (CLL) は,Bリンパ球の異常な蓄積によって特徴付けられます.
- CLLの病原性に基づく分子メカニズムを理解することは,標的治療の開発に不可欠です.
研究 の 目的:
- CLLの発症におけるDAPK1遺伝子発現の役割を調査する.
- CLLにおけるDAPK1ダウンレギュレーションの根底にある遺伝的および表遺伝的メカニズムを探求する.
主な方法:
- CLL患者におけるDAPK1遺伝子発現レベルの分析.
- DAPKに影響する遺伝子変異の調査1.
- DAPK1の発現に影響を与えるエピジェネティック変異 (例えばメチル化) の評価.
主要な成果:
- CLLにおけるDAPK1発現のダウンレギュレーションが実証された.
- 減少したDAPK1レベルに寄与する遺伝的および表遺伝的メカニズムの両方を特定しました.
- これらの変化は,家族性および散発性CLL症例の両方で観察されました.
結論:
- DAPK1のダウンレギュレーションは,CLLの病原性に関与しています.
- DAPK1の遺伝的および表遺伝的変異は,家族性および散発性CLLの両方で関連しています.
- DAPK1は,CLLにおける潜在的な治療または診断標的を代表する可能性があります.
さらに関連する動画
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.7K
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
8.9K
関連する概念動画
Overview of Cell Death
11.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
11.1K
The Intrinsic Apoptotic Pathway
9.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Disorders of Leukocytes
2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
Autophagic Cell Death
5.0K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.0K
Cytotoxic T Cells-mediated Immune Response
8.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K
